Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 May;79(5):1524-8.
doi: 10.1172/JCI112983.

Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model

J P Eder, B A Teicher, S A Holden, K N Cathcart, L E Schnipper

Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model

J P Eder et al. J Clin Invest. 1987 May.

Abstract

DNA-DNA crosslinks are the lethal cellular mechanism of bifunctional alkylating agent cytotoxicity. Novobiocin, an inhibitor of DNA topoisomerase II, impairs eukaryotic DNA repair of alkylating agent adducts and may increase the number of adducts and their resultant cytotoxicity in malignant cells. The effect of novobiocin on clonogenic survival and DNA crosslinking due to cisplatin (cDDP) and carmustine (BCNU) was studied. Novobiocin caused synergistic cytotoxicity in Chinese hamster ovary cells exposed to cDDP or BCNU. Novobiocin and cDDP increased the formation of DNA-DNA interstrand crosslinks six-fold greater than cDDP alone. The effect was schedule dependent. Novobiocin and cDDP or BCNU markedly reduced in vivo growth of a murine fibrosarcoma without increased host toxicity. As a modulating agent of cytotoxicity due to DNA-DNA crosslinking, novobiocin may enhance the clinical effectiveness of the alkylating agents in human cancer and offer insight into new therapeutic strategies.

PubMed Disclaimer

References

    1. Radiat Res. 1971 Sep;47(3):672-88 - PubMed
    1. Cancer Res. 1985 Dec;45(12 Pt 1):6523-37 - PubMed
    1. Clin Exp Immunol. 1977 Apr;28(1):1-18 - PubMed
    1. Nature. 1978 Feb 23;271(5647):713-7 - PubMed
    1. Cancer Res. 1978 Aug;38(8):2448-54 - PubMed

Publication types